| Dasatinib | Approved Investigational | HIST2H2AB | 317772 |
downregulated | Dasatinib results in decreased expression of HIST2H2AB mRNA | 1q21.2 | |
| Dasatinib | Approved Investigational | HJURP | 55355 |
downregulated | Dasatinib results in decreased expression of HJURP mRNA | 2q37.1 | |
| Dasatinib | Approved Investigational | HMCN1 | 83872 |
upregulated | Dasatinib results in increased expression of HMCN1 mRNA | 1q25.3-q31.1 | |
| Dasatinib | Approved Investigational | HMGA2 | 8091 |
downregulated | Dasatinib results in decreased expression of HMGA2 mRNA | 12q14.3 | |
| Dasatinib | Approved Investigational | HMGB2 | 3148 |
downregulated | Dasatinib results in decreased expression of HMGB2 mRNA | 4q34.1 | |
| Dasatinib | Approved Investigational | HMMR | 3161 |
downregulated | Dasatinib results in decreased expression of HMMR mRNA | 5q34 | |
| Dasatinib | Approved Investigational | HTR2B | 3357 |
upregulated | Dasatinib results in increased expression of HTR2B mRNA | 2q37.1 | |
| Dasatinib | Approved Investigational | HTRA1 | 5654 |
upregulated | Dasatinib results in increased expression of HTRA1 mRNA | 10q26.13 | |
| Dasatinib | Approved Investigational | IFIT3 | 3437 |
upregulated | Dasatinib results in increased expression of IFIT3 mRNA | 10q23.31 | |
| Dasatinib | Approved Investigational | IGF2 | 3481 |
upregulated | Dasatinib results in increased expression of IGF2 mRNA | 11p15.5 | |
| Dasatinib | Approved Investigational | IGFBP5 | 3488 |
upregulated | Dasatinib results in increased expression of IGFBP5 mRNA | 2q35 | |
| Dasatinib | Approved Investigational | IGFBP7 | 3490 |
upregulated | Dasatinib results in increased expression of IGFBP7 mRNA | 4q12 | |
| Dasatinib | Approved Investigational | IL6 | 3569 |
upregulated | Dasatinib results in increased expression of IL6 mRNA | 7p15.3 | |
| Dasatinib | Approved Investigational | IQGAP3 | 128239 |
downregulated | Dasatinib results in decreased expression of IQGAP3 mRNA | 1q22 | |
| Dasatinib | Approved Investigational | ITGA11 | 22801 |
upregulated | Dasatinib results in increased expression of ITGA11 mRNA | 15q23 | |
| Dasatinib | Approved Investigational | ITGA6 | 3655 |
downregulated | Dasatinib results in decreased expression of ITGA6 mRNA | 2q31.1 | |
| Dasatinib | Approved Investigational | ITGAV | 3685 |
upregulated | Dasatinib results in increased expression of ITGAV mRNA | 2q32.1 | |
| Dasatinib | Approved Investigational | ITGB3BP | 23421 |
downregulated | Dasatinib results in decreased expression of ITGB3BP mRNA | 1p31.3 | |
| Dasatinib | Approved Investigational | ITPR1 | 3708 |
upregulated | Dasatinib results in increased expression of ITPR1 mRNA | 3p26.1 | |
| Dasatinib | Approved Investigational | JAG1 | 182 |
upregulated | Dasatinib results in increased expression of JAG1 mRNA | 20p12.2 | |
| Dasatinib | Approved Investigational | JMY | 133746 |
upregulated | Dasatinib results in increased expression of JMY mRNA | 5q14.1 | |
| Dasatinib | Approved Investigational | KCNK2 | 3776 |
downregulated | Dasatinib results in decreased expression of KCNK2 mRNA | 1q41 | |
| Dasatinib | Approved Investigational | KIAA1524 | 57650 |
downregulated | Dasatinib results in decreased expression of KIAA1524 mRNA | 3q13.13 | |
| Dasatinib | Approved Investigational | KIF20B | 9585 |
downregulated | Dasatinib results in decreased expression of KIF20B mRNA | 10q23.31 | |
| Dasatinib | Approved Investigational | KIF23 | 9493 |
downregulated | Dasatinib results in decreased expression of KIF23 mRNA | 15q23 | |